October 19, 2017

After-Hours Gainers : Adobe Systems Incorporated (NASDAQ:ADBE), Juno Therapeutics, Inc. (NASDAQ:JUNO), Gilead Sciences, Inc. (NASDAQ:GILD)

Adobe Systems Incorporated (NASDAQ:ADBE)‘s stock on Wednesday traded at beginning with a price of $150.33 and when day-trade ended the stock finally surged 1.74% to reach at $153.00. Analyst’s mean target price for ADBE is $161.20 while analysts mean recommendation is 1.90. Stock value has moved between $98.08 – 157.73 in last one year.

Analyst’s ratings play a very important role in outlining a stock’s performance. Let us check out how analysts have ranked ADBE based on current scenarios. Stock has got OUTPERFORM rating from 12 analyst(s) whereas last month 12 analyst(s) have given outperform rating. SELL rating has been given by 1 analyst(s) and 12 analyst(s) given BUY rating to the stock. Company fiscal year is ending in November and analysts’ consensus recommendation is Outperform for ADBE and estimated EPS for next quarter is $ 1.16 .

Adobe Systems Incorporated (NASDAQ:ADBE) yearly performance is 41.12% and net profit margin is 23.10%. Annual EPS Growth of past 5 years is 7.00%. The current share price indicates that stock is -3.10% away from its one year high and is moving 56.12% ahead of its 52-week low.

On 18 October 2017, Juno Therapeutics, Inc. (NASDAQ:JUNO) stock price started the day at $43.30 and moved between $42.82 – 43.92 to finally close at $43.08. JUNO’s distance from 20 day simple moving average is -1.44% and distance from 50-Day simple moving average is 10.44%. In last 4 months performance of JUNO was 48.35% while its price to sale ratio is 58.48 and price to book ratio is 4.80.

Analysts expect Juno Therapeutics, Inc. (NASDAQ:JUNO) to report $ -0.82 EPS and has got OUTPERFORM rating from 4 of Thomson Reuters analysts and 0 analyst(s) given UNDERPERFORM rating. Analyst’s mean target price for JUNO is $35.75 while analysts mean recommendation is 2.00. Firm LT growth rate is estimated as 15.82 %.

Gilead Sciences, Inc. (NASDAQ:GILD)‘s stock on Wednesday traded at beginning with a price of $80.26 and when day-trade ended the stock finally plummeted -0.29% to reach at $80.01. Analyst’s mean target price for GILD is $81.88 while analysts mean recommendation is 2.40. Stock value has moved between $64.01 – 86.03 in last one year.

Stock has got OUTPERFORM rating from 9 analyst(s) whereas last month 8 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 5 analyst(s) given BUY rating to the stock. Company fiscal year is ending in December and analysts’ consensus recommendation is Outperform for GILD and estimated EPS for next quarter is $ 1.92 .

Gilead Sciences, Inc. (NASDAQ:GILD) yearly performance is 8.99% and net profit margin is 42.90%. Annual EPS Growth of past 5 years is 41.20%. The current share price indicates that stock is -7.25% away from its one year high and is moving 25.49% ahead of its 52-week low.

Leave a Reply

Your email address will not be published. Required fields are marked *